Breaking News, Financial News

1Q Financial Report: Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

1Q Revenues: $157.9 million (+3%)

1Q Loss: $11.5 million (earnings were $6 million in 1Q2005)

Comments: Revenues from MOVA operations were $29.4 million for the quarter compared with $23.9 million. Revenues from other sites were $128.5 million compared with $130 million in 2005. Prescription manufacturing revenues and pharmaceutical development services (PDS) revenues both increased by 5%, offset by over-the-counter (OTC) revenues, which declined by 10%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters